-
-
-
-
-
-
-
AbbVie agrees to acquire Apogee Therapeutics for $10.9 billion
-
-
-
-
-
-
-
AbbVie to Invest $380 Million in North Chicago to Further Expand Active Pharmaceutical Ingredient Manufacturing in the United States
-
-
-
-
-
-
-
AbbVie Reports Third-Quarter 2025 Financial Results
-
-
-
-
-
-
-
AbbVie to acquire depression therapy from Gilgamesh for up to $1.2 billion
-
-
-
-
-
-
-
Prime Medicine stock soars amid gene editing sector momentum
-
-
-
-
-
-
-
Bernstein provides 2025 M&A outlook for U.S. Biotech and Pharma
-
-
-
-
-
-
-
AbbVie cuts 2024 profit forecast on acquisition expenses
-
1,167,678 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

